Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells GS Inhibits PI3K/Akt Pathway
2011

Guggulsterone and Its Effects on Head and Neck Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Macha Muzafar A., Matta Ajay, Chauhan Shyam Singh, Siu K. W. Michael, Ralhan Ranju

Primary Institution: All India Institute of Medical Sciences, New Delhi, India

Hypothesis

Guggulsterone can abrogate the effects of smokeless tobacco and nicotine on apoptosis in head and neck cancer cells by activating the PI3K/Akt pathway and its downstream targets.

Conclusion

Guggulsterone treatment inhibited proliferation and induced apoptosis by blocking the effects of smokeless tobacco and nicotine on the PI3K/Akt pathway in head and neck cancer cells.

Supporting Evidence

  • Guggulsterone inhibited the activation of the PI3K/Akt pathway induced by smokeless tobacco and nicotine.
  • The study showed that guggulsterone treatment led to decreased phosphorylation of pro-apoptotic proteins Bax and Bad.
  • Guggulsterone's effects suggest its potential as a chemopreventive agent for smokeless tobacco-induced head and neck cancer.

Takeaway

Guggulsterone is a natural compound that helps fight cancer by stopping harmful substances from making cancer cells grow and survive.

Methodology

The study involved treating head and neck cancer cells with smokeless tobacco and nicotine, followed by guggulsterone, and analyzing the activation of the PI3K/Akt pathway through various assays.

Digital Object Identifier (DOI)

10.1371/journal.pone.0014728

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication